Study of Severe vomitings in pregnancy by Qurs e Hawamil
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: O210- Mild hyperemesis gravidarum
- Registration Number
- CTRI/2024/05/066639
- Lead Sponsor
- Govt Nizamia Tibbi College and General Hospital Charminar Hyderabad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pregnant with age of 18-40 years old
Pregnant women below 20 weeks of Gestation
Mild to moderate Anaemia
More than 4 episodes of vomitings per day
Primi and Multi gravida
Exclusion Criteria
PIH(Pregnancy induced Hypertension)
Pregnancy with uterine fibroid
GDM(Gestational Diabetes mellitus)
Severe Anaemia
Renal Diseases
Cholilithiasis
Cholicystiti
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vomitings will be curedTimepoint: Till 20 weeks
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Qurs e Hawamil's efficacy in treating Takhya-ul-hamal (hyperemesis gravidarum)?
How does the Unani formulation Qurs e Hawamil compare to standard antiemetics like ondansetron in managing hyperemesis gravidarum?
Are there specific biomarkers that could predict patient response to Qurs e Hawamil in hyperemesis gravidarum treatment?
What are the potential adverse events associated with Qurs e Hawamil and how are they managed in clinical practice?
What related compounds or combination therapies are being explored for hyperemesis gravidarum alongside Unani formulations like Qurs e Hawamil?